Financing the Golden Age of Biotech
In this episode of The Insight, Jerry Lee, a managing director in the Global Healthcare Investment Banking Group, discusses how the golden age of biotechnology and the current capital raising environment has created a disconnect in the market’s ability to fund new innovation across the sector. Although the current macro environment has made public markets funding challenging overall, with biopharma is no exception – the outlook for both capital raising & strategic M&A in 2023 is more positive.
Source: Dealogic and CapIQ as of 9-Dec-22